Fidelity MSCI Health Care ETF (FHLC) Holdings
FHLC holdings summary
as of Oct 24, 2026- Holdings
- 334 positions listed
- Top 10 weight
- 52.3% of net assets
- Effective holdings
- 24 equal-weight equivalent
- Largest holding
- LLY 13.36% Eli Lilly and Company
- Annual turnover
- 6.0% of the portfolio traded
Top 1052.3%
Top 2572.9%
Top 5085.8%
Top 10093.8%
Top 25099.2%
All FHLC holdings
334 holdings
| # | Name | ||||||
|---|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | Healthcare | 13.36% | $473.0M | $1.12T | 42.2 |
| 2 | JNJ | Johnson & Johnson | Healthcare | 8.27% | $292.8M | $615.87B | 38.8 |
| 3 | ABBV | AbbVie Inc. | Healthcare | 6.85% | $242.3M | $504.37B | 80.6 |
| 4 | UNH | UnitedHealth Group Incorporated | Healthcare | 4.94% | $175.0M | $360.32B | 25.8 |
| 5 | MRK | Merck & Co., Inc. | Healthcare | 4.72% | $166.9M | $360.08B | 115.8 |
| 6 | TMO | Thermo Fisher Scientific Inc. | Healthcare | 3.43% | $121.4M | $255.13B | 37.1 |
| 7 | AMGN | Amgen Inc. | Healthcare | 3.28% | $116.1M | $233.82B | 26.9 |
| 8 | GILD | Gilead Sciences, Inc. | Healthcare | 2.64% | $93.5M | $193.67B | — |
| 9 | ABT | Abbott Laboratories | Healthcare | 2.40% | $85.1M | $181.50B | 33.8 |
| 10 | PFE | Pfizer Inc. | Healthcare | 2.37% | $83.9M | $168.60B | 38.9 |
| 11 | ISRG | Intuitive Surgical, Inc. | Healthcare | 1.96% | $69.2M | $150.74B | 48.9 |
| 12 | DHR | Danaher Corporation | Healthcare | 1.84% | $65.2M | $161.01B | 40.8 |
| 13 | VRTX | Vertex Pharmaceuticals Incorporated | Healthcare | 1.74% | $61.6M | $126.66B | 28.9 |
| 14 | MCK | McKesson Corporation | Healthcare | 1.66% | $58.9M | $117.15B | 26.9 |
| 15 | CVS | CVS Health Corporation | Healthcare | 1.66% | $58.8M | $118.13B | 24.3 |
| 16 | BMY | Bristol-Myers Squibb Company | Healthcare | 1.66% | $58.7M | $122.05B | 13.2 |
| 17 | MDT | Medtronic plc | Healthcare | 1.62% | $57.3M | $121.20B | 23.3 |
| 18 | SYK | Stryker Corporation | Healthcare | 1.45% | $51.3M | $113.02B | 30.5 |
| 19 | ELV | Elevance Health Inc. | Healthcare | 1.24% | $43.9M | $92.88B | 19.0 |
| 20 | REGN | Regeneron Pharmaceuticals, Inc. | Healthcare | 1.05% | $37.3M | $81.41B | 19.6 |
| 21 | CI | Cigna Corporation | Healthcare | 1.04% | $36.9M | $79.88B | 12.5 |
| 22 | MRNA | Moderna, Inc. | Healthcare | 1.04% | $36.7M | $87.04B | — |
| 23 | HCA | HCA Healthcare, Inc. | Healthcare | 0.97% | $34.4M | $99.34B | 15.4 |
| 24 | BSX | Boston Scientific Corporation | Healthcare | 0.87% | $30.8M | $64.33B | 18.0 |
| 25 | COR | Cencora | Healthcare | 0.83% | $29.5M | $65.06B | 25.3 |
| 26 | CAH | Cardinal Health, Inc. | Healthcare | 0.82% | $29.0M | $58.83B | 35.1 |
| 27 | NTRA | Natera, Inc. | Healthcare | 0.73% | $26.0M | $56.71B | — |
| 28 | BDX | Becton, Dickinson and Company | Healthcare | 0.71% | $25.2M | $52.23B | 44.6 |
| 29 | HUM | Humana Inc. | Healthcare | 0.70% | $24.7M | $49.61B | 39.1 |
| 30 | EW | Edwards Lifesciences Corporation | Healthcare | 0.68% | $24.0M | $49.92B | 51.5 |
| 31 | A | Agilent Technologies, Inc. | Healthcare | 0.62% | $22.0M | $48.77B | 34.1 |
| 32 | VEEV | Veeva Systems Inc. | Healthcare | 0.62% | $21.8M | $50.25B | 50.9 |
| 33 | IDXX | IDEXX Laboratories, Inc. | Healthcare | 0.60% | $21.4M | $44.20B | 39.8 |
| 34 | IQV | IQVIA Holdings Inc. | Healthcare | 0.59% | $21.0M | $43.93B | 33.2 |
| 35 | WAT | Waters Corporation | Healthcare | 0.55% | $19.4M | $42.90B | 110.6 |
| 36 | ILMN | Illumina, Inc. | Healthcare | 0.52% | $18.4M | $39.64B | 49.0 |
| 37 | RMD | ResMed Inc. | Healthcare | 0.49% | $17.3M | $33.61B | 22.9 |
| 38 | BIIB | Biogen Inc. | Healthcare | 0.48% | $16.9M | $34.37B | 41.3 |
| 39 | DXCM | DexCom, Inc. | Healthcare | 0.46% | $16.1M | $32.47B | 34.1 |
| 40 | MTD | Mettler-Toledo International Inc. | Healthcare | 0.46% | $16.1M | $32.51B | 36.6 |
| 41 | ZTS | Zoetis Inc. | Healthcare | 0.45% | $15.8M | $32.80B | 13.1 |
| 42 | CNC | Centene Corporation | Healthcare | 0.44% | $15.6M | $34.16B | — |
| 43 | RVMD | Revolution Medicines, Inc. | Healthcare | 0.44% | $15.6M | $38.14B | — |
| 44 | GEHC | GE HealthCare Technologies Inc. | Healthcare | 0.42% | $14.9M | $31.42B | 16.0 |
| 45 | ALNY | Alnylam Pharmaceuticals, Inc. | Healthcare | 0.41% | $14.7M | $31.02B | 39.1 |
| 46 | WST | West Pharmaceutical Services, Inc. | Healthcare | 0.36% | $12.6M | $27.03B | 49.4 |
| 47 | RPRX | Royalty Pharma plc | Healthcare | 0.35% | $12.4M | $35.22B | 32.4 |
| 48 | LH | Laboratory Corporation of America Holdings | Healthcare | 0.35% | $12.3M | $25.79B | 26.3 |
| 49 | DGX | Quest Diagnostics Incorporated | Healthcare | 0.34% | $12.2M | $25.94B | 24.6 |
| 50 | THC | Tenet Healthcare Corporation | Healthcare | 0.33% | $11.5M | $21.52B | 10.5 |
| 51 | UTHR | United Therapeutics Corporation | Healthcare | 0.29% | $10.3M | $22.87B | 19.1 |
| 52 | STE | STERIS plc | Healthcare | 0.29% | $10.3M | $21.71B | 27.2 |
| 53 | VTRS | Viatris Inc. | Healthcare | 0.27% | $9.7M | $21.43B | — |
| 54 | INSM | Insmed Incorporated | Healthcare | 0.27% | $9.5M | $21.02B | — |
| 55 | INCY | Incyte Corporation | Healthcare | 0.27% | $9.5M | $22.92B | 14.4 |
| 56 | GH | Guardant Health, Inc. | Healthcare | 0.26% | $9.4M | $21.28B | — |
| 57 | ZBH | Zimmer Biomet Holdings, Inc. | Healthcare | 0.26% | $9.1M | $18.12B | 23.1 |
| 58 | ROIV | Roivant Sciences Ltd. | Healthcare | 0.24% | $8.3M | $24.22B | — |
| 59 | RVTY | Revvity, Inc. | Healthcare | 0.22% | $7.8M | $17.03B | 73.0 |
| 60 | EXEL | Exelixis, Inc. | Healthcare | 0.20% | $7.2M | $15.42B | 19.6 |
| 61 | CRL | Charles River Laboratories International, Inc. | Healthcare | 0.20% | $7.1M | $14.46B | — |
| 62 | MEDP | Medpace Holdings, Inc. | Healthcare | 0.20% | $7.0M | $17.26B | 36.3 |
| 63 | HALO | Halozyme Therapeutics, Inc. | Healthcare | 0.20% | $6.9M | $13.83B | 35.6 |
| 64 | NBIX | Neurocrine Biosciences, Inc. | Healthcare | 0.18% | $6.5M | $13.79B | 19.9 |
| 65 | MDLN | Medline Inc. | Healthcare | 0.18% | $6.4M | $48.38B | 89.9 |
| 66 | SOLV | Solventum Corporation | Healthcare | 0.16% | $5.8M | $14.61B | 10.5 |
| 67 | BAX | Baxter International Inc. | Healthcare | 0.16% | $5.8M | $13.07B | — |
| 68 | JAZZ | Jazz Pharmaceuticals plc | Healthcare | 0.16% | $5.7M | $13.65B | 14.4 |
| 69 | PEN | Penumbra, Inc. | Healthcare | 0.16% | $5.7M | $12.64B | 78.8 |
| 70 | EHC | Encompass Health Corporation | Healthcare | 0.16% | $5.7M | $12.61B | 21.4 |
| 71 | CORT | Corcept Therapeutics Incorporated | Healthcare | 0.16% | $5.5M | $11.91B | 244.8 |
| 72 | TECH | Bio-Techne Corporation | Healthcare | 0.15% | $5.5M | $11.38B | 62.6 |
| 73 | AVTR | Avantor, Inc. | Healthcare | 0.15% | $5.4M | $11.11B | — |
| 74 | COO | The Cooper Companies, Inc. | Healthcare | 0.15% | $5.2M | $11.02B | 19.9 |
| 75 | MOH | Molina Healthcare, Inc. | Healthcare | 0.15% | $5.2M | $10.82B | — |
| 76 | ELAN | Elanco Animal Health Incorporated | Healthcare | 0.14% | $5.1M | $11.76B | — |
| 77 | BTSG | BrightSpring Health Services, Inc. | Healthcare | 0.14% | $5.0M | $12.04B | 53.9 |
| 78 | RGEN | Repligen Corporation | Healthcare | 0.14% | $4.9M | $11.14B | 240.3 |
| 79 | PODD | Insulet Corporation | Healthcare | 0.13% | $4.8M | $9.79B | 26.4 |
| 80 | GKOS | Glaukos Corporation | Healthcare | 0.13% | $4.7M | $9.72B | — |
| 81 | ALGN | Align Technology, Inc. | Healthcare | 0.13% | $4.7M | $10.46B | 25.6 |
| 82 | BMRN | BioMarin Pharmaceutical Inc. | Healthcare | 0.13% | $4.7M | $10.58B | 147.8 |
| 83 | BBIO | BridgeBio Pharma, Inc. | Healthcare | 0.13% | $4.6M | $12.98B | — |
| 84 | UHS | Universal Health Services, Inc. | Healthcare | 0.13% | $4.6M | $10.91B | 7.6 |
| 85 | ENSG | The Ensign Group, Inc. | Healthcare | 0.13% | $4.5M | $10.29B | 27.7 |
| 86 | GMED | Globus Medical, Inc. | Healthcare | 0.12% | $4.1M | $10.30B | 19.7 |
| 87 | HQY | HealthEquity, Inc. | Healthcare | 0.11% | $3.9M | $7.61B | 33.2 |
| 88 | HSIC | Henry Schein, Inc. | Healthcare | 0.11% | $3.8M | $9.63B | 25.2 |
| 89 | PCVX | Vaxcyte, Inc. | Healthcare | 0.11% | $3.8M | $10.01B | — |
| 90 | TGTX | TG Therapeutics, Inc. | Healthcare | 0.11% | $3.8M | $8.26B | 19.6 |
| 91 | TWST | Twist Bioscience Corporation | Healthcare | 0.10% | $3.7M | $8.80B | — |
| 92 | TXG | 10x Genomics, Inc. | Healthcare | 0.10% | $3.6M | $9.10B | — |
| 93 | CYTK | Cytokinetics, Incorporated | Healthcare | 0.10% | $3.5M | $8.61B | — |
| 94 | IONS | Ionis Pharmaceuticals, Inc. | Healthcare | 0.09% | $3.3M | $7.14B | — |
| 95 | PTGX | Protagonist Therapeutics, Inc. | Healthcare | 0.09% | $3.3M | $8.33B | 125.0 |
| 96 | MDGL | Madrigal Pharmaceuticals, Inc. | Healthcare | 0.09% | $3.3M | $10.39B | — |
| 97 | ARWR | Arrowhead Pharmaceuticals, Inc. | Healthcare | 0.09% | $3.3M | $7.90B | — |
| 98 | TEM | Tempus AI, Inc. | Healthcare | 0.09% | $3.3M | $11.68B | — |
| 99 | ALKS | Alkermes plc | Healthcare | 0.09% | $3.3M | $6.92B | 108.5 |
| 100 | CHE | Chemed Corporation | Healthcare | 0.09% | $3.2M | $6.70B | 25.8 |
| 101 | KRYS | Krystal Biotech, Inc. | Healthcare | 0.09% | $3.1M | $9.37B | 39.7 |
| 102 | AXSM | Axsome Therapeutics, Inc. | Healthcare | 0.09% | $3.1M | $8.23B | — |
| 103 | LNTH | Lantheus Holdings, Inc. | Healthcare | 0.09% | $3.1M | $6.51B | 24.1 |
| 104 | PRAX | Praxis Precision Medicines, Inc. | Healthcare | 0.08% | $3.0M | $6.75B | — |
| 105 | BIO | Bio-Rad Laboratories, Inc. | Healthcare | 0.08% | $2.9M | $9.46B | 44.8 |
| 106 | HIMS | Hims & Hers Health, Inc. | Healthcare | 0.08% | $2.8M | $6.55B | — |
| 107 | LGND | Ligand Pharmaceuticals Incorporated | Healthcare | 0.08% | $2.8M | $5.89B | 31.1 |
| 108 | BRKR | Bruker Corporation | Healthcare | 0.08% | $2.7M | $8.35B | — |
| 109 | SYRE | Spyre Therapeutics, Inc. | Healthcare | 0.08% | $2.7M | $7.47B | — |
| 110 | KYMR | Kymera Therapeutics, Inc. | Healthcare | 0.08% | $2.7M | $8.62B | — |
| 111 | TFX | Teleflex Incorporated | Healthcare | 0.08% | $2.7M | $5.53B | — |
| 112 | IOVA | Iovance Biotherapeutics, Inc. | Healthcare | 0.08% | $2.7M | $6.17B | — |
| 113 | DVA | DaVita Inc. | Healthcare | 0.07% | $2.7M | $11.95B | 15.8 |
| 114 | MMSI | Merit Medical Systems, Inc. | Healthcare | 0.07% | $2.4M | $5.33B | 36.7 |
| 115 | HAE | Haemonetics Corporation | Healthcare | 0.07% | $2.4M | $5.38B | 57.1 |
| 116 | SHC | Sotera Health Company | Healthcare | 0.07% | $2.4M | $5.11B | 31.4 |
| 117 | RYTM | Rhythm Pharmaceuticals, Inc. | Healthcare | 0.07% | $2.4M | $5.91B | — |
| 118 | HNGE | Hinge Health, Inc. | Healthcare | 0.07% | $2.3M | $8.00B | 32.7 |
| 119 | RDNT | RadNet, Inc. | Healthcare | 0.06% | $2.2M | $5.41B | — |
| 120 | CON | Concentra Group Holdings Parent, Inc. | Healthcare | 0.06% | $2.1M | $4.91B | 24.9 |
| 121 | GRAL | GRAIL, Inc. | Healthcare | 0.06% | $2.1M | $5.26B | — |
| 122 | PTCT | PTC Therapeutics, Inc. | Healthcare | 0.06% | $2.1M | $4.94B | — |
| 123 | TVTX | Travere Therapeutics, Inc. | Healthcare | 0.06% | $2.1M | $4.61B | — |
| 124 | OPCH | Option Care Health, Inc. | Healthcare | 0.06% | $2.1M | $4.67B | 23.6 |
| 125 | CRSP | CRISPR Therapeutics AG | Healthcare | 0.06% | $2.0M | $4.76B | — |
| 126 | LIVN | LivaNova PLC | Healthcare | 0.06% | $2.0M | $4.26B | 23.0 |
| 127 | COGT | Cogent Biosciences, Inc. | Healthcare | 0.06% | $2.0M | $5.12B | — |
| 128 | ITGR | Integer Holdings Corporation | Healthcare | 0.06% | $2.0M | $4.31B | 34.6 |
| 129 | DFTX | Definium Therapeutics, Inc. | Healthcare | 0.05% | $1.9M | $4.31B | — |
| 130 | DOCS | Doximity, Inc. | Healthcare | 0.05% | $1.9M | $5.52B | 36.4 |
| 131 | IRTC | iRhythm Technologies, Inc. | Healthcare | 0.05% | $1.8M | $3.58B | — |
| 132 | NVST | Envista Holdings Corporation | Healthcare | 0.05% | $1.8M | $3.68B | 39.5 |
| 133 | HTFL | Heartflow, Inc. | Healthcare | 0.05% | $1.8M | $4.20B | — |
| 134 | ICUI | ICU Medical, Inc. | Healthcare | 0.05% | $1.8M | $4.08B | 137.0 |
| 135 | ARQT | Arcutis Biotherapeutics, Inc. | Healthcare | 0.05% | $1.7M | $3.62B | 131.0 |
| 136 | MIRM | Mirum Pharmaceuticals, Inc. | Healthcare | 0.05% | $1.7M | $5.20B | — |
| 137 | INDV | Indivior PLC | Healthcare | 0.05% | $1.7M | $3.83B | 11.6 |
| 138 | OGN | Organon & Co. | Healthcare | 0.05% | $1.7M | $3.61B | 17.6 |
| 139 | SRRK | Scholar Rock Holding Corporation | Healthcare | 0.05% | $1.6M | $4.86B | — |
| 140 | VCYT | Veracyte, Inc. | Healthcare | 0.05% | $1.6M | $3.47B | 30.8 |
| 141 | WAY | Waystar Holding Corp. | Healthcare | 0.04% | $1.5M | $5.25B | 39.1 |
| 142 | KNSA | Kiniksa Pharmaceuticals, Ltd. | Healthcare | 0.04% | $1.5M | $6.13B | 79.4 |
| 143 | NK | NantKwest Inc | Healthcare | 0.04% | $1.4M | — | — |
| 144 | NHC | National HealthCare Corporation | Healthcare | 0.04% | $1.4M | $3.80B | 27.0 |
| 145 | ORKA | Oruka Therapeutics, Inc. | Healthcare | 0.04% | $1.4M | $4.76B | — |
| 146 | IDYA | IDEAYA Biosciences, Inc. | Healthcare | 0.04% | $1.4M | $3.17B | — |
| 147 | CDNA | CareDx, Inc | Healthcare | 0.04% | $1.4M | $3.31B | 30.8 |
| 148 | AMRX | Amneal Pharmaceuticals, Inc. | Healthcare | 0.04% | $1.4M | $6.68B | 39.1 |
| 149 | CGON | CG Oncology, Inc. | Healthcare | 0.04% | $1.4M | $5.31B | — |
| 150 | XENE | Xenon Pharmaceuticals Inc. | Healthcare | 0.04% | $1.4M | $3.24B | — |
| 151 | ADPT | Adaptive Biotechnologies Corporation | Healthcare | 0.04% | $1.4M | $3.83B | — |
| 152 | VKTX | Viking Therapeutics, Inc. | Healthcare | 0.04% | $1.4M | $3.20B | — |
| 153 | DNTH | Dianthus Therapeutics, Inc. | Healthcare | 0.04% | $1.4M | $4.03B | — |
| 154 | KOD | Kodiak Sciences Inc. | Healthcare | 0.04% | $1.4M | $5.39B | — |
| 155 | CAI | Caris Life Sciences, Inc. | Healthcare | 0.04% | $1.3M | $8.64B | 18.1 |
| 156 | ATRC | AtriCure, Inc. | Healthcare | 0.04% | $1.3M | $2.85B | 267.0 |
| 157 | LFST | LifeStance Health Group, Inc. | Healthcare | 0.04% | $1.3M | $4.46B | 90.3 |
| 158 | DNLI | Denali Therapeutics Inc. | Healthcare | 0.04% | $1.3M | $2.81B | — |
| 159 | ERAS | Erasca, Inc. | Healthcare | 0.03% | $1.2M | $4.68B | — |
| 160 | BCTG | BCTG Acquisition Corp | Financial Services | 0.03% | $1.1M | — | — |
| 161 | ACHC | Acadia Healthcare Company, Inc. | Healthcare | 0.03% | $1.1M | $2.79B | — |
| 162 | AMLX | Amylyx Pharmaceuticals, Inc. | Healthcare | 0.03% | $1.1M | $3.31B | — |
| 163 | LQDA | Liquidia Corporation | Healthcare | 0.03% | $1.1M | $3.07B | 24.7 |
| 164 | CRVL | CorVel Corporation | Financial Services | 0.03% | $1.1M | $4.03B | 35.6 |
| 165 | ADMA | ADMA Biologics, Inc. | Healthcare | 0.03% | $1.1M | $2.39B | 15.3 |
| 166 | TMDX | TransMedics Group, Inc. | Healthcare | 0.03% | $1.1M | $2.45B | 18.3 |
| 167 | NEOG | Neogen Corporation | Healthcare | 0.03% | $1.1M | $2.58B | — |
| 168 | BEAM | Beam Therapeutics Inc. | Healthcare | 0.03% | $1.1M | $2.42B | — |
| 169 | SLS | SELLAS Life Sciences Group, Inc. | Healthcare | 0.03% | $1.1M | $2.02B | — |
| 170 | PBH | Prestige Consumer Healthcare Inc. | Healthcare | 0.03% | $1.1M | $2.36B | 14.0 |
| 171 | ACAD | ACADIA Pharmaceuticals Inc. | Healthcare | 0.03% | $1.1M | $3.29B | 8.6 |
| 172 | SUPN | Supernus Pharmaceuticals, Inc. | Healthcare | 0.03% | $1.1M | $2.21B | — |
| 173 | DYN | Dyne Therapeutics, Inc. | Healthcare | 0.03% | $1.1M | $2.66B | — |
| 174 | PRVA | Privia Health Group, Inc. | Healthcare | 0.03% | $1.1M | $2.88B | 107.2 |
| 175 | MD | Pediatrix Medical Group, Inc. | Healthcare | 0.03% | $1.1M | $2.22B | 13.1 |
| 176 | PRGO | Perrigo Company plc | Healthcare | 0.03% | $1.1M | $2.30B | — |
| 177 | RLAY | Relay Therapeutics, Inc. | Healthcare | 0.03% | $1.0M | $3.57B | — |
| 178 | ADUS | Addus HomeCare Corporation | Healthcare | 0.03% | $1.0M | $2.17B | 20.3 |
| 179 | SMMT | Summit Therapeutics Inc. | Healthcare | 0.03% | $1.0M | $11.67B | — |
| 180 | TARS | Tarsus Pharmaceuticals, Inc. | Healthcare | 0.03% | $1.0M | $3.19B | — |
| 181 | UFPT | UFP Technologies, Inc. | Healthcare | 0.03% | $1.0M | $2.26B | 31.5 |
| 182 | BKD | Brookdale Senior Living Inc. | Healthcare | 0.03% | $1.0M | $2.41B | — |
| 183 | FTRE | Fortrea Holdings Inc. | Healthcare | 0.03% | $1.0M | $2.14B | — |
| 184 | PGNY | Progyny, Inc. | Healthcare | 0.03% | $1.0M | $2.06B | 29.2 |
| 185 | CLDX | Celldex Therapeutics, Inc. | Healthcare | 0.03% | $998,053.54 | $2.16B | — |
| 186 | PACS | PACS Group, Inc. | Healthcare | 0.03% | $994,514.34 | $7.43B | 27.4 |
| 187 | AGIO | Agios Pharmaceuticals, Inc. | Healthcare | 0.03% | $990,975.15 | $1.87B | — |
| 188 | NEO | NeoGenomics, Inc. | Healthcare | 0.03% | $983,896.75 | $2.14B | — |
| 189 | ELVN | Enliven Therapeutics, Inc. | Healthcare | 0.03% | $980,357.55 | $2.73B | — |
| 190 | VCEL | Vericel Corporation | Healthcare | 0.03% | $966,200.77 | $2.05B | 85.4 |
| 191 | CLOV | Clover Health Investments, Corp. | Healthcare | 0.03% | $959,122.37 | $2.38B | — |
| 192 | EWTX | Edgewise Therapeutics, Inc. | Healthcare | 0.03% | $941,426.39 | $4.04B | — |
| 193 | RCUS | Arcus Biosciences, Inc. | Healthcare | 0.02% | $863,564.06 | $2.82B | — |
| 194 | AXGN | AxoGen, Inc. | Healthcare | 0.02% | $849,407.27 | $2.03B | — |
| 195 | SRPT | Sarepta Therapeutics, Inc. | Healthcare | 0.02% | $838,789.68 | $1.81B | — |
| 196 | IMVT | Immunovant, Inc. | Healthcare | 0.02% | $838,789.68 | $5.52B | — |
| 197 | XERS | Xeris Biopharma Holdings, Inc. | Healthcare | 0.02% | $835,250.48 | $1.88B | — |
| 198 | LMAT | LeMaitre Vascular, Inc. | Healthcare | 0.02% | $835,250.48 | $1.85B | 28.4 |
| 199 | INSP | Inspire Medical Systems, Inc. | Healthcare | 0.02% | $828,172.09 | $1.99B | 15.2 |
| 200 | AUP | Aurinia Pharmaceuticals Inc | Technology | 0.02% | $821,093.69 | — | — |
| 201 | HRMY | Harmony Biosciences Holdings, Inc. | Healthcare | 0.02% | $817,554.50 | $2.21B | 12.2 |
| 202 | ALHC | Alignment Healthcare, Inc. | Healthcare | 0.02% | $817,554.50 | $1.72B | 43.6 |
| 203 | IRON | Disc Medicine, Inc. | Healthcare | 0.02% | $814,015.30 | $2.18B | — |
| 204 | XRAY | DENTSPLY SIRONA Inc. | Healthcare | 0.02% | $810,476.10 | $1.71B | — |
| 205 | NVAX | Novavax, Inc. | Healthcare | 0.02% | $806,936.90 | $1.86B | — |
| 206 | ASTH | Astrana Health, Inc. | Healthcare | 0.02% | $803,397.71 | $1.83B | 44.3 |
| 207 | VRDN | Viridian Therapeutics, Inc. | Healthcare | 0.02% | $796,319.31 | $2.16B | — |
| 208 | MANE | Veradermics, Incorporated | Healthcare | 0.02% | $796,319.31 | $4.55B | — |
| 209 | IMNM | Immunome, Inc. | Healthcare | 0.02% | $792,780.12 | $1.94B | — |
| 210 | RXRX | Recursion Pharmaceuticals, Inc. | Healthcare | 0.02% | $789,240.92 | $1.86B | — |
| 211 | NVCR | NovoCure Limited | Healthcare | 0.02% | $785,701.72 | $1.64B | — |
| 212 | CELC | Celcuity Inc. | Healthcare | 0.02% | $753,848.95 | $2.77B | — |
| 213 | AZTA | Azenta, Inc. | Healthcare | 0.02% | $746,770.56 | $1.49B | — |
| 214 | SDGR | Schrödinger, Inc. | Healthcare | 0.02% | $739,692.16 | $1.69B | — |
| 215 | AMN | AMN Healthcare Services, Inc. | Healthcare | 0.02% | $736,152.97 | $1.57B | 15.1 |
| 216 | INVA | Innoviva, Inc. | Healthcare | 0.02% | $736,152.97 | $1.50B | 4.9 |
| 217 | NRIX | Nurix Therapeutics, Inc. | Healthcare | 0.02% | $732,613.77 | $2.67B | 10.0 |
| 218 | OMCL | Omnicell, Inc. | Healthcare | 0.02% | $732,613.77 | $1.61B | 42.1 |
| 219 | CNMD | CONMED Corporation | Healthcare | 0.02% | $721,996.18 | $1.40B | 25.3 |
| 220 | NTLA | Intellia Therapeutics, Inc. | Healthcare | 0.02% | $718,456.98 | $1.60B | — |
| 221 | BCRX | BioCryst Pharmaceuticals, Inc. | Healthcare | 0.02% | $718,456.98 | $1.99B | — |
| 222 | BHVN | Biohaven Ltd. | Healthcare | 0.02% | $665,369.03 | $1.63B | — |
| 223 | VIR | Vir Biotechnology, Inc. | Healthcare | 0.02% | $658,290.63 | $1.69B | — |
| 224 | RARE | Ultragenyx Pharmaceutical Inc. | Healthcare | 0.02% | $644,133.84 | $1.43B | — |
| 225 | KH6_old | KINGHERO | Other | 0.02% | $626,437.86 | — | — |
| 226 | URGN | UroGen Pharma Ltd. | Healthcare | 0.02% | $626,437.86 | $1.69B | — |
| 227 | BFLY | Butterfly Network, Inc. | Healthcare | 0.02% | $626,437.86 | $1.93B | — |
| 228 | PNTG | The Pennant Group, Inc. | Healthcare | 0.02% | $622,898.66 | $1.46B | 46.0 |
| 229 | PCRX | Pacira BioSciences, Inc. | Healthcare | 0.02% | $622,898.66 | $1.45B | 103.8 |
| 230 | ATEC | Alphatec Holdings, Inc. | Healthcare | 0.02% | $622,898.66 | $1.62B | — |
| 231 | PGEN | Precigen, Inc. | Healthcare | 0.02% | $619,359.47 | $2.28B | — |
| 232 | PVLA | Palvella Therapeutics, Inc | Healthcare | 0.02% | $608,741.88 | $1.73B | — |
| 233 | USPH | U.S. Physical Therapy, Inc. | Healthcare | 0.02% | $608,741.88 | $1.28B | 476.2 |
| 234 | ABSI | Absci Corporation | Healthcare | 0.02% | $608,741.88 | $1.42B | — |
| 235 | VERA | Vera Therapeutics, Inc. | Healthcare | 0.02% | $598,124.28 | $2.01B | — |
| 236 | MLYS | Mineralys Therapeutics, Inc. | Healthcare | 0.02% | $598,124.28 | $1.79B | — |
| 237 | ANIP | ANI Pharmaceuticals, Inc. | Healthcare | 0.02% | $594,585.09 | $1.66B | 15.6 |
| 238 | SGRY | Surgery Partners, Inc. | Healthcare | 0.02% | $580,428.30 | $1.91B | — |
| 239 | QURE | uniQure N.V. | Healthcare | 0.02% | $548,575.53 | $1.51B | — |
| 240 | MBX | MBX Biosciences, Inc. | Healthcare | 0.02% | $545,036.33 | $2.39B | — |
| 241 | ESTA | Establishment Labs Holdings Inc. | Healthcare | 0.02% | $545,036.33 | $1.76B | — |
| 242 | WGS | GeneDx Holdings Corp. | Healthcare | 0.02% | $541,497.13 | $1.90B | — |
| 243 | NUVB | Nuvation Bio Inc. | Healthcare | 0.02% | $541,497.13 | $1.56B | — |
| 244 | GRDN | Guardian Pharmacy Services, Inc. | Healthcare | 0.02% | $537,957.94 | $2.50B | 38.3 |
| 245 | ZA8 | ZYMEWORKS DL-00001 | Healthcare | 0.02% | $537,957.94 | — | — |
| 246 | ETON | Eton Pharmaceuticals, Inc. | Healthcare | 0.02% | $534,418.74 | $1.44B | 125.8 |
| 247 | OMER | Omeros Corporation | Healthcare | 0.01% | $530,879.54 | $1.17B | 13.3 |
| 248 | TNDM | Tandem Diabetes Care, Inc. | Healthcare | 0.01% | $527,340.35 | $1.13B | — |
| 249 | XNCR | Xencor, Inc. | Healthcare | 0.01% | $523,801.15 | $1.70B | — |
| 250 | ENOV | Enovis Corporation | Healthcare | 0.01% | $520,261.95 | $1.13B | — |
| 251 | AVAH | Aveanna Healthcare Holdings Inc. | Healthcare | 0.01% | $520,261.95 | $2.69B | 9.8 |
| 252 | CERT | Certara, Inc. | Healthcare | 0.01% | $520,261.95 | $1.43B | — |
| 253 | TRVI | Trevi Therapeutics, Inc. | Healthcare | 0.01% | $516,722.75 | $1.69B | — |
| 254 | NKTR | Nektar Therapeutics | Healthcare | 0.01% | $513,183.56 | $1.22B | — |
| 255 | TDOC | Teladoc Health, Inc. | Healthcare | 0.01% | $509,644.36 | $1.03B | — |
| 256 | STOK | Stoke Therapeutics, Inc. | Healthcare | 0.01% | $509,644.36 | $1.56B | — |
| 257 | PRCT | PROCEPT BioRobotics Corporation | Healthcare | 0.01% | $506,105.16 | $1.00B | — |
| 258 | TRAX | First Tracks Biotherapeutics | Healthcare | 0.01% | $467,174.00 | $1.23B | — |
| 259 | OCUL | Ocular Therapeutix, Inc. | Healthcare | 0.01% | $463,634.80 | $1.51B | — |
| 260 | SNDX | Syndax Pharmaceuticals, Inc. | Healthcare | 0.01% | $463,634.80 | $1.15B | — |
| 261 | AORT | Artivion, Inc. | Healthcare | 0.01% | $460,095.60 | $1.06B | — |
| 262 | CSU | Capital Senior Living Corporation | Healthcare | 0.01% | $453,017.21 | — | — |
| 263 | NUTX | Nutex Health, Inc. | Healthcare | 0.01% | $453,017.21 | $1.27B | 7.4 |
| 264 | QDEL | QuidelOrtho Corporation | Healthcare | 0.01% | $453,017.21 | $885.3M | — |
| 265 | CSTL | Castle Biosciences, Inc. | Healthcare | 0.01% | $435,321.22 | $976.4M | — |
| 266 | AGL | agilon health, inc. | Healthcare | 0.01% | $424,703.63 | $1.43B | — |
| 267 | HROW | Harrow Health, Inc. | Healthcare | 0.01% | $424,703.63 | $1.02B | — |
| 268 | PAHC | Phibro Animal Health Corporation | Healthcare | 0.01% | $407,007.65 | $1.58B | 16.0 |
| 269 | IART | Integra LifeSciences Holdings Corporation | Healthcare | 0.01% | $403,468.45 | $1.03B | — |
| 270 | MNKD | MannKind Corporation | Healthcare | 0.01% | $403,468.45 | $977.5M | — |
| 271 | SIBN | SI-BONE, Inc. | Healthcare | 0.01% | $399,929.26 | $872.8M | — |
| 272 | AMPH | Amphastar Pharmaceuticals, Inc. | Healthcare | 0.01% | $399,929.26 | $1.10B | 15.3 |
| 273 | PSNL | Personalis, Inc. | Healthcare | 0.01% | $396,390.06 | $1.67B | — |
| 274 | HSTM | HealthStream, Inc. | Healthcare | 0.01% | $385,772.47 | $1.01B | 46.0 |
| 275 | RAPP | Rapport Therapeutics, Inc. | Healthcare | 0.01% | $385,772.47 | $1.32B | — |
| 276 | ANAB | AnaptysBio, Inc. | Healthcare | 0.01% | $385,772.47 | $1.39B | — |
| 277 | PLSE | Pulse Biosciences, Inc. | Healthcare | 0.01% | $382,233.27 | $3.17B | — |
| 278 | OMDA | Omada Health, Inc. | Healthcare | 0.01% | $357,458.89 | $1.08B | 73.5 |
| 279 | MRVI | Maravai LifeSciences Holdings, Inc. | Healthcare | 0.01% | $353,919.69 | $2.51B | — |
| 280 | MAZE | Maze Therapeutics, Inc. | Healthcare | 0.01% | $350,380.50 | $1.53B | — |
| 281 | TSHA | Taysha Gene Therapies, Inc. | Healthcare | 0.01% | $350,380.50 | $1.18B | — |
| 282 | ZBIO | Zenas BioPharma, Inc. | Healthcare | 0.01% | $343,302.10 | $1.62B | — |
| 283 | KURA | Kura Oncology, Inc. | Healthcare | 0.01% | $343,302.10 | $807.8M | — |
| 284 | IRMD | IRadimed Corporation | Healthcare | 0.01% | $339,762.91 | $1.13B | 49.3 |
| 285 | COLL | Collegium Pharmaceutical, Inc. | Healthcare | 0.01% | $339,762.91 | $755.0M | 18.3 |
| 286 | ARDX | Ardelyx, Inc. | Healthcare | 0.01% | $339,762.91 | $797.8M | — |
| 287 | JANX | Janux Therapeutics, Inc. | Healthcare | 0.01% | $339,762.91 | $1.01B | — |
| 288 | LBRX | LB Pharmaceuticals Inc | Healthcare | 0.01% | $322,066.92 | $1.19B | 367.4 |
| 289 | INBX | Inhibrx, Inc. | Healthcare | 0.01% | $318,527.73 | $1.32B | — |
| 290 | KMTS | Kestra Medical Technologies, Ltd. | Healthcare | 0.01% | $311,449.33 | $1.62B | — |
| 291 | SEPN | Septerna, Inc. | Healthcare | 0.01% | $307,910.13 | $1.70B | — |
| 292 | STAA | STAAR Surgical Company | Healthcare | 0.01% | $307,910.13 | $1.07B | 265.9 |
| 293 | OPK | OPKO Health, Inc. | Healthcare | 0.01% | $307,910.13 | $1.14B | — |
| 294 | PHR | Phreesia, Inc. | Healthcare | 0.01% | $307,910.13 | $679.1M | 64.4 |
| 295 | GERN | Geron Corporation | Healthcare | 0.01% | $300,831.74 | $751.7M | — |
| 296 | JBIO | Jade Biosciences, Inc. | Healthcare | 0.01% | $300,831.74 | $856.7M | — |
| 297 | CRVS | Corvus Pharmaceuticals, Inc. | Healthcare | 0.01% | $297,292.54 | $800.8M | — |
| 298 | ORIC | ORIC Pharmaceuticals, Inc. | Healthcare | 0.01% | $293,753.35 | $1.28B | — |
| 299 | AVTX | Avalo Therapeutics, Inc. | Healthcare | 0.01% | $286,674.95 | $604.4M | — |
| 300 | CGEM | Cullinan Oncology, Inc. | Healthcare | 0.01% | $276,057.36 | $794.7M | — |
| 301 | CRMD | CorMedix Inc. | Healthcare | 0.01% | $251,282.98 | $565.9M | 3.5 |
| 302 | AHCO | AdaptHealth Corp. | Healthcare | 0.01% | $251,282.98 | $803.1M | — |
| 303 | MGTX | MeiraGTx Holdings plc | Healthcare | 0.01% | $244,204.59 | $891.3M | 10.7 |
| 304 | GLUE | Monte Rosa Therapeutics, Inc. | Healthcare | 0.01% | $240,665.39 | $831.0M | — |
| 305 | DMRA | Damora Therapeutics, Inc. | Healthcare | 0.01% | $240,665.39 | $1.14B | — |
| 306 | BCAX | Bicara Therapeutics Inc. | Healthcare | 0.01% | $240,665.39 | $1.11B | — |
| 307 | TKM | Arbutus Biopharma Corp | Other | 0.01% | $230,047.80 | — | — |
| 308 | ANRO | Alto Neuroscience, Inc. | Healthcare | 0.01% | $230,047.80 | $861.0M | — |
| 309 | COAG | Hemab Therapeutics Holdings, Inc. | Healthcare | 0.01% | $230,047.80 | $1.40B | — |
| 310 | TYRA_old | TYRA | Healthcare | 0.01% | $226,508.60 | — | — |
| 311 | AVBP | ArriVent BioPharma, Inc. | Healthcare | 0.01% | $222,969.41 | $821.5M | — |
| 312 | KLRA | Kailera Therapeutics, Inc. | Healthcare | 0.01% | $222,969.41 | $1.46B | — |
| 313 | CTMX | CytomX Therapeutics, Inc. | Healthcare | 0.01% | $222,969.41 | $496.8M | — |
| 314 | ANNX | Annexon, Inc. | Healthcare | 0.01% | $222,969.41 | $646.5M | — |
| 315 | MLTX_old | Multex Com Inc | Other | 0.01% | $219,430.21 | — | — |
| 316 | WVE | Wave Life Sciences Ltd. | Healthcare | 0.01% | $215,891.01 | $616.8M | — |
| 317 | SVRA | Savara Inc. | Healthcare | 0.01% | $201,734.23 | $914.3M | — |
| 318 | VOR | Vor Biopharma Inc. | Healthcare | 0.01% | $201,734.23 | $977.0M | 0.1 |
| 319 | PRME | Prime Medicine, Inc. | Healthcare | 0.01% | $201,734.23 | $629.4M | — |
| 320 | ARVN | Arvinas, Inc. | Healthcare | 0.01% | $191,116.64 | $449.7M | 26.8 |
| 321 | SANA | Sana Biotechnology, Inc. | Healthcare | 0.01% | $184,038.24 | $679.5M | — |
| 322 | ALMS | Alumis Inc. | Healthcare | 0.01% | $180,499.04 | $792.1M | — |
| 323 | AVLN | Avalyn Pharma Inc. | Healthcare | 0.01% | $176,959.85 | $1.05B | — |
| 324 | OLMA | Olema Pharmaceuticals, Inc. | Healthcare | 0.00% | $173,420.65 | $575.7M | — |
| 325 | TLRY | Tilray Brands, Inc. | Healthcare | 0.00% | $166,342.26 | $449.3M | — |
| 326 | DNA | Ginkgo Bioworks Holdings, Inc. | Healthcare | 0.00% | $166,342.26 | $691.6M | — |
| 327 | PHAT | Phathom Pharmaceuticals, Inc. | Healthcare | 0.00% | $159,263.86 | $559.8M | — |
| 328 | GDRX | GoodRx Holdings, Inc. | Healthcare | 0.00% | $155,724.67 | $1.15B | 67.2 |
| 329 | LXRX | Lexicon Pharmaceuticals, Inc. | Healthcare | 0.00% | $152,185.47 | $676.3M | — |
| 330 | CAPR | Capricor Therapeutics, Inc. | Healthcare | 0.00% | $148,646.27 | $390.1M | — |
| 331 | SPRY | ARS Pharmaceuticals, Inc. | Healthcare | 0.00% | $88,479.92 | $399.8M | — |
| 332 | BIOA | BioAge Labs, Inc | Healthcare | 0.00% | $74,323.14 | $222.1M | — |
| 333 | SION | Sionna Therapeutics, Inc. | Healthcare | 0.00% | $24,774.38 | $175.6M | — |
| 334 | EYPT | EyePoint Pharmaceuticals, Inc. | Healthcare | 0.00% | $10,617.59 | $250.7M | — |
Weights as a percentage of net assets. Value held = weight × net assets ($3.54B). Market cap and P/E from each company's latest fundamentals (U.S.-listed stocks).
FHLC sector breakdown
| Sector | Weight | Holdings | Largest |
|---|---|---|---|
| Healthcare | 99.8% | 328 | LLY, JNJ, ABBV |
| Financial Services | 0.1% | 2 | BCTG, CRVL |
| Other | 0.0% | 3 | KH6_old, TKM, MLTX_old |
| Technology | 0.0% | 1 | AUP |
Sum of the weights of the holdings in each sector.
FHLC top industries
Drug Manufacturers - General
43.7%
Diagnostics & Research
11.3%
Biotechnology
10.6%
Healthcare Plans
10.3%
Medical Devices
9.8%
Medical Instruments & Supplies
5.0%
Medical Distribution
3.4%
Medical Care Facilities
2.4%
Drug Manufacturers - Specialty & Generic
2.0%
Health Information Services
1.3%
Shell Companies
0.0%
Insurance Brokers
0.0%
Technical & System Software
0.0%
FHLC overlap with other ETFs
| ETF | Fund | Overlap | Shared holdings | Expense ratio |
|---|---|---|---|---|
| VHT | Vanguard Health Care ETF | 96.2% | 317 of 406 | 0.10% |
| IYH | iShares U.S. Healthcare ETF | 87.9% | 97 of 99 | 0.39% |
| XLV | Health Care Select Sector SPDR Fund | 86.3% | 60 of 60 | 0.09% |
| TRUH | VanEck Healthcare TruSector ETF | 86.3% | 60 of 60 | — |
| IXJ | iShares Global Healthcare ETF | 73.1% | 60 of 106 | 0.42% |
| RXL | ProShares Ultra Health Care | 63.0% | 60 of 61 | 0.93% |
Overlap = sum over shared holdings of the smaller of the two weights. 100% means identical portfolios.
About the FHLC portfolio
Fidelity MSCI Health Care ETF holds 334 positions. The ten largest make up 52.3% of the fund and the top 50 85.8%, so it behaves like a portfolio of about 24 equally weighted stocks. The biggest positions are Eli Lilly and Company (13.36%), Johnson & Johnson (8.27%), AbbVie Inc. (6.85%), UnitedHealth Group Incorporated (4.94%), Merck & Co., Inc. (4.72%).
By sector, Healthcare is 99.8%, Financial Services is 0.1%, Other is 0.0%. Holdings data is from the fund's latest portfolio as reported by EODHD on October 24, 2026; positions change as the fund rebalances.
Related: FHLC chart, FHLC performance, FHLC dividends, FHLC valuation, FHLC overview.
FHLC holdings FAQ
How many holdings does FHLC have?
FHLC holds 334 positions as of October 24, 2026.
What are the top 10 holdings of FHLC?
The ten largest holdings are Eli Lilly and Company (13.36%), Johnson & Johnson (8.27%), AbbVie Inc. (6.85%), UnitedHealth Group Incorporated (4.94%), Merck & Co., Inc. (4.72%), Thermo Fisher Scientific Inc. (3.43%), Amgen Inc. (3.28%), Gilead Sciences, Inc. (2.64%), Abbott Laboratories (2.40%), Pfizer Inc. (2.37%). Together they are 52.3% of the fund.
What percentage of FHLC is Eli Lilly and Company?
Eli Lilly and Company is the largest holding at 13.36% of net assets, about $473.0M of the fund's $3.54B.
Which sector is the largest in FHLC?
Healthcare is the largest sector at 99.8%, followed by Financial Services (0.1%) and Other (0.0%), based on the sectors of the individual holdings.
How concentrated is FHLC?
The top 10 holdings are 52.3% of the fund. By the effective number of holdings (1 divided by the sum of squared weights) FHLC behaves like a portfolio of about 24 equally weighted stocks.